Topics
View Supplement
Rebecca Hepp, Editor-in-Chief
Rosa L. Pinheiro, MD; Filipe Henriques, MD; João Figueira, PhD; Mário Alfaiate, MD; and Joaquim N. Murta, PhD
Kyle D. Kovacs, MD, and Szilárd Kiss, MD
May/June 2022 Insert
Sponsored by OcuTerra
Supported by Allergan, an AbbVie company
Sponsored by NIDEKMirante does not have US FDA clearance.
May/June 2022 Supplement
Editorially Independent Content, Supported with Advertising from Alcon Surgical and LumiThera
This activity is supported by an unrestricted educational grant from Genentech, a member of the Roche Group.
Recent Supplements
One to Watch: Hong-Uyen Hua, MD
Editorially independent supported by Abbvie and Regenxbio
View Insert
Gaining Patients’ Buy-in With Geographic Atrophy Treatment: The Journey From Diagnosis to Long-term Adherence
Editorially Independent Content, Supported With Advertising From Astellas
Rising Stars in Retina: Fares Antaki, MDCM
One to Watch: Jordan D. Deaner, MD
Understanding Fast Progression in Geographic Atrophy
Navigating Copays in Retina Care
View More
Eyetube Retina Series
EYETUBE RETINA MEETING COVERAGE
